A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Clinical trial NCT05714839 · RECRUITING
Trial details
- NCT number
- NCT05714839
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2028-08-03
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.